ENSOMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Feb 2024)
What this means for you
This application is over — abandoned 12 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90019881
- Mark type
- Stylized text
- Filed
- 25 Jun 2020
- Published for opposition
- 17 Nov 2020
- Abandoned
- 12 Feb 2024
- Attorney of record
- Caitlin Byczko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of diseases, namely, genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism
Owner
- ENSOMA, INC., Boston, MA, US
- ENSOMA, INC., BOSTON, MA, US
- Veevo Biomedicines, Inc., Boston, MA, US
Prosecution history
- 12 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2023 — SOU EXTENSION 5 GRANTED
- 12 Jun 2023 — SOU EXTENSION 5 FILED
- 12 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2022 — SOU EXTENSION 4 GRANTED
- 16 Nov 2022 — SOU EXTENSION 4 FILED
- 16 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 13 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 May 2022 — SOU EXTENSION 3 GRANTED
- 11 May 2022 — SOU EXTENSION 3 FILED
- 11 May 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED